Sign Out
Treatment of advanced breast cancer in post-menopausal women with oestrogen receptor positive and or progesterone receptor positive.
Adjuvant treatment of post-menopausal women with hormone receptor positive early invasive breast cancer.
Adjuvant treatment of early breast cancer in hormone receptor positive post-menopausal women, who have received 2 to 3 years of adjuvant tamoxifen.
